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Abstract 
Background and Objective:  The causal role of maternal nutrition in orofacial clefts is 
uncertain. We tested hypotheses that low maternal vitamin B12 and low folate status are each 
associated with an increased risk of isolated cleft lip, with or without cleft palate, (CL+P) in a 
case-control study in Tamil Nadu state, India. 
Methods: Case-mothers of CL+P children (n=47) and control-mothers of unaffected children 
(n=50) were recruited an average of 1.4 years after birth of the index child and plasma vitamin 
B12, methylmalonic acid (MMA), total homocysteine (tHcy), and folate were measured at that 
time. Logistic regression analyses estimated associations between nutrient biomarkers and 
case-control status. 
Results: Odds ratios (ORs) contrasting biomarker levels showed associations between case-
mothers and low vs. high plasma vitamin B12 (OR=2.48, 95% CI 1.02, 6.01) and high vs. low 
plasma MMA, an indicator of poor B12 status (OR=3.65 95% CI 1.21, 11.05). Case-control status 
was not consistently associated with folate or tHCY levels.  Low vitamin B12 status, when 
defined by a combination of both plasma vitamin B12 and MMA levels, had an even stronger 
association with case-mothers (OR=6.54, 95% CI 1.33, 32.09). 
Conclusions: Mothers of CL+P children in southern India were 6.5 times more likely to have 
poor vitamin B12 status, defined by multiple biomarkers, compared to control-mothers. Further 
studies in populations with diverse nutritional backgrounds are required to determine whether 
poor maternal vitamin B12 or folate levels or their interactions are causally related to CL+P. 
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Introduction 
Orofacial clefts (OFCs) are among the most common birth defects with considerable 
geographic, racial, ethnic, and socioeconomic variation in occurrence. (Mossey, Little et al. 
2009)  Maternal folate nutrition is of interest given the success of folic acid in preventing neural 
tube defects (NTDs) (MRC Vitamin Study Research Group 1991) and the fact that OFCs and 
NTDs share some developmental pathways (Kousa, Mansour et al. 2017) however the role of 
folate in OFCs is uncertain (Munger, Sauberlich et al. 2004, Johnson and Little 2008, Munger, 
Tamura et al. 2011, De-Regil, Pena-Rosas et al. 2015)  Vitamin B12 is an essential co-factor in 
folate-related one-carbon metabolism but its possible role in OFCs has received much less 
attention than folate. Experimental animal studies have provided some evidence of a causal role 
for poor maternal vitamin B12 status in the etiology of OFCs (Mann and Gautieri 1973, He, 
Meng et al. 2010, Zhang, Wang et al. 2011) but studies of maternal vitamin B12 status and 
OFCs in humans are few in number with varied methods and inconsistent results (van Rooij, 
Swinkels et al. 2003, Shaw, Vollset et al. 2009, Vujkovic, Steegers et al. 2010, Sutton, Mills et 
al. 2011, Wallenstein, Shaw et al. 2013, Blanco, Colombo et al. 2016)  Further insight from 
human studies of the associations between maternal vitamin B12 and folate nutrition and OFCs 
may lead to global public health efforts to prevent OFCs.  
The birth prevalence of OFCs in India is not well defined due to limited population-based 
birth defect surveillance and the high mortality of infants with OFCs may result in under-
ascertainment of cases. (Mossey and Little 2009)  The high prevalence of vitamin B12 deficiency 
in India has been linked to many adverse reproductive health outcomes including spontaneous 
abortion, intrauterine growth retardation, fetal adiposity, insulin resistance, and gestational 
diabetes.(Muthayya, Kurpad et al. 2006, Rosenberg 2008, Yajnik, Deshpande et al. 2008, 
Krishnaveni, Hill et al. 2009, Katre, Bhat et al. 2010, Dwarkanath, Barzilay et al. 2013)   
Investigations of the role of maternal nutrition in causing OFCs are difficult in prospective 
cohort studies because OFCs are rare, requiring the follow-up of 500-1000 pregnancies to find 
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each birth of a child with an OFC, hence such a study would be very costly.  We and others 
have employed case-control studies with maternal nutrient biomarkers, based on the premise 
that maternal dietary habits and social environments are relatively stable before and after 
pregnancy and genetic and epigenetic factors that influence blood biomarkers levels are fixed 
(Leck, Iles et al. 1983, van Rooij, Swinkels et al. 2003, Munger, Sauberlich et al. 2004, Tamura, 
Munger et al. 2005, Tamura, Munger et al. 2007, Munger, Tamura et al. 2011); in these studies 
maternal biomarker associations with birth defects have persisted for years after the affected 
birth and may provide clues to the etiology and prevention of OFCs.  
Multiple biomarkers provide a more detailed and in-depth assessment of vitamin B12 and 
folate status, respectively, than single biomarkers. (Bailey, Stover et al. 2015, Green, Allen et al. 
2017)  Validation studies with comparisons of assay results from independent laboratories are 
important but unfortunately are not reported in many publications, especially in reports on folate 
status. (Pfeiffer, Zhang et al. 2011)  We employed assays of multiple biomarker indicators of 
maternal vitamin B12 status (plasma vitamin B12 and methylmalonic acid) and folate status 
(microbiologic and liquid chromatography-tandem mass spectrometry assays of plasma folate) 
and total plasma homocysteine, an indicator of both B12 and folate status, and report on 
validation findings.  With these biomarkers we tested the hypotheses that low maternal vitamin 
B12 status and low folate status are each associated with an increased risk of isolated cleft lip, 
with or without cleft palate, (CL+P) in a case-control study in Tamil Nadu state, India. 
Methods 
A case-control study of associations between maternal plasma nutrient biomarkers and 
risk of OFCs was conducted in the Thiruvallur, Kanchipuram, and Chennai districts of Tamil 
Nadu state, India. The case definition for mothers included last child born with a cleft lip, with or 
without cleft palate (CL+P), and with no other birth defect or known genetic etiology, ascertained 
via the surgical records of the Cleft and Craniofacial Center of Sri Ramachandra University 
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Hospital (SRUH) in Chennai and reviewed by the Director, J.M. The controls were mothers 
residing and giving birth in the same geographic area as case-mothers and were recruited from 
the Tamil Nadu Air Pollution Health Effects (TAPHE) study, an ongoing prospective, community-
based cohort study of the effects of air pollution on pregnant women and their children thus 
representative of the population from which the case-mothers were drawn. (Balakrishnan, 
Sambandam et al. 2015)  Study participants lived within a 1-2 hour drive to SRUH and free 
transportation to SRUH was provided for case and control mothers. Control-mothers had no 
child ever born with a birth defect and were frequency-matched with a 1:1 ratio to case-mothers 
by maternal age-group (18-22, 23-27, 28-32 years) and age-group of their last live-born child 
(<6, 6-11, 12-17, 18-23, 24-29, 30-35, 36-41 months).  Informed consent was obtained from all 
mothers via protocols approved by the institutional review boards of Sri Ramachandra 
University, Utah State University, USA, and the India Council of Medical Research. Mothers 
were interviewed, had clinical examinations, and had blood samples collected during the period 
May-July 2014 and the included births of case and control children were between January 2012 
and September 2013.  The sample size of 50 case-mothers and 50 control-mothers was 
determined by resource limitations. 
 Trained members of the research team conducted interviews in the local Tamil language 
to collect demographic data, lifestyle data, and health histories of study participants and family 
members.  Information on breastfeeding, including direct breastfeeding and expressing breast 
milk for bottle feeding at the time of blood collection, was obtained because of the concern that 
this may affect maternal blood nutrient levels. (Jathar, Kamath et al. 1970, Obeid, Sole-Navais 
et al. 2017)  Data on the duration of breastfeeding at the time of maternal blood collection were 
not available. Weight was measured on a Samso Progress 150 digital weighing scale and 
height was measured with a Seca 213 stadiometer.  Maternal venous blood samples were 
collected by trained phlebotomists from the antecubital fossa in evacuated tubes with EDTA 
anticoagulant.  The blood tubes were placed in wet ice immediately upon mixing and centrifuged 
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within two hours of collection.  Plasma aliquots were immediately drawn off after centrifugation 
then stored at -80 degrees until assayed for biomarkers. 
 Plasma vitamin B12 was determined by electrochemiluminescence (Elecsys 2010, Roche 
Diagnostics, Mannheim, Germany). Methylmalonic acid (MMA), an indicator of B12 status related 
to mitochondrial metabolism, and total homocysteine (tHcy), an indicator of both B12 and folate  
status, were measured by gas chromatography-mass spectrometry (Varian 3800, Palo Alto, CA, 
USA) at the Division of Nutrition, St. John’s Research Institute, Bangalore, India, via methods 
previously published.(Duggan, Srinivasan et al. 2014) Validation assays of a sub-sample for 
plasma vitamin B12 were performed with a microbiologic method (Kelleher and Broin 1991) at 
the Biomedical Sciences Institute, Trinity College, Dublin, Ireland.  Plasma folate was 
determined by a microbiological method (Molloy and Scott 1997) and validation assays of a sub-
sample for folate forms were performed with liquid chromatography-tandem mass spectrometry 
methods (Bjorke-Monsen, Torsvik et al. 2008) at Bevital (www.bevital.com), Bergen, Norway. All 
assays were performed without knowledge of the case-control status of the samples. Validation 
assays of each analyte were performed in different laboratories without knowledge of the results 
from the assay with which they were compared. 
Studies were completed with 50 case-mothers and 50 control-mothers.  Of the 55 case-
mothers that were sought out, five (nine percent) could not be contacted and there were no 
refusals.  Of the 72 control-mothers that were sought out, 12 (17 percent) could not be 
contacted and 10 (14 percent) refused.  Two of the case-mothers were excluded from analyses 
because their children were found to have an isolated cleft palate without a cleft lip, a group 
thought to be etiologically distinct from cases with CL+P (Mossey, Little et al. 2009) and one 
case-mother was excluded due to missing biomarker data.  The remaining 47 case-children had 
no other birth defects. 
 The Statistical Package for the Social Sciences (IBM Corp. IBM SPSS Statistics for 
Windows, Version 25.0. Armonk, NY: IBM Corp) was used to calculate medians and 
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interquartile ranges of demographic and biomarker variables, and Spearman Rank-Order 
correlation coefficients between biomarkers; medians were compared with the independent 
samples non-parametric median test. Unconditional logistic regression models were used, as is 
appropriate for frequency-matching by age in case-control studies (Kuo, Duan et al. 2018), to 
calculate odds ratios and their 95 percent confidence intervals as estimates of relative risk of 
CL+P by level of maternal plasma nutrient biomarker.  The restricted sample size did not allow 
analyses over a graded series of finer biomarker levels to evaluate dose-response relationships, 
hence only two levels were compared, above and below the median for controls, to maximize 
the statistical power of comparing higher vs. lower biomarker groups.  Plasma vitamin B12 and 
MMA determinations are overlapping but distinct measures of vitamin B12 nutritional status 
hence a cross-classification with both measures may better define adequate vs. sub-optimal 
vitamin B12 status (Green, Allen et al. 2017)  therefore additional analyses were completed that 
compared exposure levels defined by combinations of vitamin B12 and MMA levels.  Adjusted 
odds ratios were calculated in logistic regression models that included maternal age (due to a 
two-year median difference between case and control maternal ages despite frequency-
matching), rural vs. urban residence, and current breastfeeding status, including direct 
breastfeeding and expressing breast milk for infant bottle feeding, at the time of blood sample 
collection.  A covariate for breastfeeding status at the time of maternal blood collection was 
included because previous publications have reported lower blood nutrient levels in 
breastfeeding vs. non-breastfeeding mothers in India. (Jathar, Kamath et al. 1970, Obeid, Sole-
Navais et al. 2017) 
 
Results  
 The demographic characteristics and biomarker levels of study participants are 
summarized in Table 1.  Case-children were slightly older than controls at the time of maternal 
blood collection (median 1.8 vs 1.2 years). Fewer case-children were female (36 percent; 1:1.8 
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female-male ratio) than controls (52 percent female) which is consistent with the 1:2 female-
male sex ratio for infants born with CL+P in European populations. (Mossey and Little 2002) 
Case-mothers, compared to controls, were marginally younger, taller, heavier, and had more 
rural residences. Fewer case-mothers than controls were breastfeeding at the time of study, 
consistent with the known difficulties in breast feeding children with orofacial clefts. (Goyal, 
Chopra et al. 2014)  Median plasma vitamin B12 was lower in case-mothers vs. controls (232.0 
vs. 286.3 pmol/L respectively, p = 0.04).  Median MMA was higher in case-mothers vs. controls 
(0.36 vs. 0.32 umol/L respectively, p = 0.03), also an indication of poorer vitamin B12 status in 
case-mothers. Median tHcy levels were marginally higher in case vs. control-mothers (10.7 vs. 
9.6 umol/L respectively, p = 0.54), and median folate levels were marginally lower in case-
mothers vs. controls (10.7 vs. 12.9 nmol/L respectively, p = 0.27).   All case and control-mothers 
reported receiving iron-folate supplements from public health centers during pregnancy and 
none reported taking these supplements at the time of interview and blood collection.  Iron-
folate supplements are offered free by local public health clinics to pregnant women for the 
purpose of prevention of anemia, intrauterine growth retardation, and maternal growth stunting 
rather than as an effort to prevent birth defects and the supplements are typically taken up in the 
second trimester, after the period of OFC formation. (Kumar 1999, Mason, Saldanha et al. 2012)  
None of the mothers reported taking vitamin B12 supplements during or after pregnancy. 
Spearman rank-order correlation coefficients for comparisons of biomarkers appear in 
Table 2 for all mothers combined. The number of validation assays was limited by the remaining 
sample volumes of split aliquots.  Fifty-eight aliquots were assayed for plasma vitamin B12 with 
the microbiologic method (B12-MB) in the laboratory of A.M. and these values were highly 
correlated with the assays performed with the electrochemiluminsecence method (B12-ECL) 
used in the full sample in the laboratory of A.K. (r = 0.89, p < 0.001).  Thirty-three aliquots were 
assayed for plasma folate forms with the liquid chromatography-tandem mass spectrometry 
method (Folate-LC-MS/MS) (Ueland, Midttun et al. 2007) in the Bevital laboratory and the 
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values for total folates, computed as the sum of 5-methyltetrahydrofolate plus the oxidized form, 
4-hydroxy-5-methyltetrahydrofolate, were highly correlated with the assays performed with the 
microbiologic method (Folate-MB) used in the full sample in the laboratory of A.M. (r = 0.87, p < 
0.001).  The correlations for the validation assays were similar for cases and controls when the 
analyses were stratified by case-control status (data not shown). 
 The correlations in Table 2 also reveal expected associations between the biomarkers of 
one-carbon metabolism.  Both methods of plasma vitamin B12 assay revealed similar 
correlations with plasma MMA (B12-ECL: r =-0.35, p < 0.001); B12-MB: r = - 0.39, p = 0.002).  In 
addition, both methods of plasma vitamin B12 assay revealed similar correlations with plasma 
tHcy (B12-ECL: r =-0.25, p = 0.01; B12-MB: r = - 0.21, p = 0.11).  The results of the two vitamin 
B12 assays and the MMA assay were not significantly associated with either of the folate assays, 
indicating that vitamin B12 status in this sample was not associated with folate status.  Each of 
the folate assays was similarly correlated with plasma tHcy (Folate-MB: r = -0.44, p < 0.001; 
Folate-LC-MS/MS: r = -0.41, p = 0.02) 
 The associations between nutrient biomarker levels and case-control status, estimated 
as odds ratios and 95 percent confidence intervals (CIs) comparing mothers above and below 
the median plasma biomarker levels, appear in Table 3. The logistic regression models included 
covariates of age of mother (due to residual differences in case and control maternal ages 
despite frequency-matching), rural vs. urban residence, and breastfeeding status.  Case-
mothers were 2.48 times more likely than control mothers to have a lower plasma vitamin B12 
level (OR = 2.48; 95 percent CI: 1.02, 6.01) than having a higher plasma vitamin B12 level.  
Case-mothers were 3.65 times more likely than control-mothers to have a higher plasma MMA 
acid level (an indicator of poorer vitamin B12 status) than having a lower plasma MMA acid level 
(OR = 3.65; 95 percent CI: 1.21, 11.05).  Higher vs. lower level of tHcy had an odds ratio of 
2.08, but the 95 percent CI (0.73, 5.90) broadly included 1.0, weaker evidence of association 
compared to the vitamin B12 and MMA results.  Similarly, lower vs. higher level of plasma folate 
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had an adjusted odds ratio of 2.87, but the 95 percent CI (0.72, 11.46) also broadly included 
1.0, also weaker evidence of association compared to the vitamin B12 and MMA results. 
 The results of logistic regression models estimating the association between combined 
vitamin B12 biomarker levels and case-control status appear in Table 4.  With the low-risk 
reference level defined as plasma vitamin B12 above the median and MMA below the median, 
the adjusted odds ratio (OR) for low risk level of plasma vitamin B12 (above median) combined 
with high risk level of MMA (above median) was 0.90 (95 percent CI: 0.17, 4.80) and the 
adjusted OR for high risk level of plasma vitamin B12 (below median) combined with low risk 
level of MMA (below median) was 0.74 (95 percent CI: 0.15, 3.48).  Only the group with 
combined high risk level of plasma vitamin B12 (below median) and high risk level of MMA 
(above median) showed a stronger association with case-mothers (adjusted OR = 6.54, 95 
percent CI: 1.33, 32.09) than the single analyses of these vitamin B12 status indicators.  Thus 
case-mothers were 6.5 times more likely to have poor vitamin B12 status, defined by multiple 
biomarkers, compared to control-mothers. 
The prevalence of breastfeeding was higher among the control-mothers (62 percent) 
compared to case-mothers (13 percent) and we found that plasma B12 was lower and MMA was 
higher in breastfeeding (BF) vs. non-breastfeeding (NBF) mothers in both case and control-
mothers when these groups were examined separately. Among BF case-mothers vitamin B12 
was 24 percent lower and MMA was 36 percent higher compared to NBF case-mothers.  
Among BF control-mothers vitamin B12 was 8 percent lower and MMA was 6 percent higher 
compared to NBF control-mothers. To further explore the possibility that case-control 
differences in breastfeeding prevalence may have somewhat biased associations we restricted 
the logistic regression analyses to NBF mothers only and found that OFC association with low 
B12 was similar among NBF only (OR = 2.67, 95% CI 0.76,9.33) compared to the overall results 
(OR = 2.48, 95% CI: 1.02, 6.01); association with high MMA among NBF only was higher (OR = 
5.00 , 95% CI: 1.26, 19.82) compared to the overall results (OR = 3.65, 95% CI: 1.21, 11.05); 
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and association with the joint level of low B12 and high MMA among NBF only was higher (OR 
= 11.13, 95% CI: 1.45, 85.79) compared to the overall results (OR = 6.54, 95% CI: 1.33, 32.09).  
There was a 0.6-year difference between the median ages of case-children and control-children 
at the time of maternal blood collection and we felt this was unlikely to confound the analyses of 
maternal biomarker differences; to assess this further we repeated all logistic regression 
analyses with the addition of a covariate for child age and the results were unchanged. 
  
Discussion 
Mothers of CL+P children in the Tamil Nadu study in southern India were more likely to 
have poor vitamin B12 status, defined by lower maternal plasma vitamin B12 and elevated 
plasma MMA levels.  An analysis with a more precise definition poor vitamin B12 status using a 
combination of plasma vitamin B12 and MMA levels revealed an even stronger association with 
poor vitamin B12 status.  
The possible role of vitamin B12 in OFC prevention has received much less attention 
than folate though both are interrelated co-factors in one-carbon metabolism. Both are required 
for the remethylation of tHcy to form methionine, important for the methylation of DNA, RNA, 
and histone proteins involved in the epigenetic regulation of gene expression and for the 
synthesis of neurotransmitters, phosphatidylcholine, and other small molecules important in fetal 
development. (Bailey, Stover et al. 2015)  In vitamin B12 deficiency, folate is “trapped” in the 
unusable methyl-form resulting in perturbations of thymidine synthesis and DNA replication 
resulting in genomic instability. (Herbert and Zalusky 1962, Green, Allen et al. 2017)  Vitamin 
B12 is an essential co-factor of methyl-malonyl CoA mutase in mitochondrial metabolism thus B12 
deficiency results in elevated MMA which disrupts mitochondrial function leading to elevated 
levels of inflammatory cytokines and generation of excess levels reactive oxygen species. 
(Fenech 2012)  The precise role of these or other molecular mechanisms involving vitamin B12  
in the disruption of development and formation of OFCs is not known.   
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Experimental animal and cell culture models of OFCs induced by cortisone, retinoic acid, 
and dexamethasone have shown that vitamin B12 reduces the occurrence of chemically induced 
OFCs.(Mann and Gautieri 1973, He, Meng et al. 2010, Zhang, Wang et al. 2011)  The relevance 
of these models for humans is uncertain as these studies used different methods, chemical 
exposures for OFC induction, and doses of vitamin B12.   
Studies of maternal vitamin B12 status and OFCs in humans are few in number with 
varied methods and inconsistent results. A case-control study in California found an increased 
risk of OFCs among mothers in the lowest quartile of self-reported dietary intake of vitamin B12, 
but only among non-users of vitamin supplements and there was no association among 
supplement users. (Wallenstein, Shaw et al. 2013)   A case-control study in the Netherlands 
initially found a lower mean maternal serum vitamin B12 level in case-mothers compared to 
control-controls (van Rooij, Swinkels et al. 2003) but a later report from the same study found a 
less significant difference.(Vujkovic, Steegers et al. 2010)  A nested case-control study in 
California of mid-pregnancy serum vitamin B12 found no association between vitamin B12 level 
and risk of OFCs. (Shaw, Vollset et al. 2009)  An Irish prospective study of maternal serum 
samples collected at 15 weeks gestation found significantly higher vitamin B12 levels among 
mothers later giving birth to children with OFCs compared to controls.(Sutton, Mills et al. 2011).  
A meta-analysis of seven studies that collected blood specimens from case and control 
mothers, all from North American and European populations with generally more sufficient 
vitamin B12 levels compared to South Asian populations, found no overall association with 
measured vitamin B12 level however the heterogeneity between studies in timing of blood 
collection, laboratory methods for analyses, ethnicity, and the nutritional backgrounds of the 
study populations limited the conclusions of this meta-analysis. (Blanco, Colombo et al. 2016) 
Biomarkers measured in samples taken during pregnancy are affected by pregnancy-associated 
hemodilution (plasma volume expansion), changes in renal function, and hormonal changes, 
with large inter-individual and inter-population variations (Faupel-Badger, Hsieh et al. 2007) thus 
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blood samples collected during pregnancy may not accurately reflect maternal nutritional status 
at the time of conception and during OFC formation in the earliest weeks of pregnancy.  Blood 
samples in the Tamil Nadu study were collected a mean of 1.4 years after delivery.  We are not 
aware of other biomarker studies of vitamin B12 and risk of OFCs in India or other South Asian 
populations with dietary patterns quite different than North American and European populations.  
Plasma folate was not significantly associated with CL+P in the present study, though 
larger studies may indeed show associations.  A systematic review and meta-analysis that 
reviewed studies of dietary folate intake, folate food fortification, and genetic and biomarker 
indicators of folate status suggested no association between these measures and OFC risk, 
though substantial heterogeneity between studies was cited as a limitation.(Johnson and Little 
2008)  A Cochrane systematic review found no evidence from folate intervention trials of a 
preventive effect on OFCs, though the trials were considered low-quality evidence based on 
design issues and limited power to detect OFC outcomes (De-Regil, Pena-Rosas et al. 2015)    
The meta-analysis by Blanco et al. cited previously included 10 case-control studies with 
measurement of plasma folate and found no overall association with OFC risk; the conclusions 
were limited by the same reasons cited previously.(Blanco, Colombo et al. 2016).  We are not 
aware of other biomarker studies of folate and risk of OFCs in India or other South Asian 
populations. 
Other nutrients required in one-carbon metabolism have been associated with OFCs 
including vitamin B6 (Davis, Nelson et al. 1970, Munger, Sauberlich et al. 2004, Tamura, Munger 
et al. 2007) and zinc (Hurley and Swenerton 1966, Krapels, Rooij et al. 2004, Tamura, Munger 
et al. 2005, Hozyasz, Kaczmarczyk et al. 2009)  A case-control study in the Philippines found 
that poor plasma vitamin B6 and zinc levels, co-factors with both folate and vitamin B12  in one-
carbon metabolism, were each very common and each strongly associated with OFC risk.  
Plasma folate was inconsistently associated with OFCs in the Philippines due to an interaction 
with vitamin B6 status.(Munger, Sauberlich et al. 2004)  In a Utah case-control study very few 
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deficiencies in vitamin B6 and zinc were found and hence neither were associated with OFC risk 
(Munger, Tamura et al. 2009, Munger, Tamura et al. 2011)  These findings indicate that studies 
in populations with diverse dietary backgrounds and employing a wider variety of biomarkers of 
nutrients involved in one-carbon metabolism and their interactions will be important to furthering 
understanding of maternal nutrition and risk of OFCs.      
A limitation of the Tamil Nadu study is that it was retrospective without observation of 
diet and maternal nutrient biomarkers at conception and in the period of lip and palate 
development early in the first trimester.  Prospective cohort studies of birth defects would allow 
tracking of maternal nutritional status before and during pregnancy but would require very large 
sample sizes of observed pregnancies to observe an adequate number of affected infants, thus 
case-control studies are a more practical study design, but not without limitations. Our approach 
to nutrient biomarker analyses in the Tamil Nadu case-control study was based on the premise 
that maternal dietary habits and social environments in this setting are relatively stable before 
and after pregnancy and genetic and epigenetic factors that influence blood biomarkers levels 
are fixed.   Prospective studies have provided evidence that dietary patterns are stable between 
pre-conceptional and postpartum periods. (Devine, Bove et al. 2000, Cuco, Fernandez-Ballart et 
al. 2006)    Leck et al, in early studies of neural tube defects in North London, found significant 
correlations between blood folate levels measured early in pregnancy and measured in blood 
samples collected from mothers 1-2 years after delivery and concluded that such studies of 
maternal samples collected after delivery “are well worth pursuing as a possible means of 
identifying associations of aetiological significance between maternal nutritional status and 
malformations.” (Leck, Iles et al. 1983)  In other studies of OFCs that have used this approach 
maternal biomarker associations appear to have persisted for years after the affected birth.(van 
Rooij, Swinkels et al. 2003, Munger, Sauberlich et al. 2004, Tamura, Munger et al. 2005, 
Tamura, Munger et al. 2007, Munger, Tamura et al. 2011) 
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A description of dose-response relationships between nutrient biomarkers and CL+P risk 
was not possible due to the restricted sample size.  To maximize the statistical power of 
comparisons “higher” and “lower” biomarker groups were defined by median levels of 
biomarkers.  Published standards for defining marginal levels of nutritional biomarkers have not 
been based on OFC risk nor are they specific for India, but they are useful to provide evidence 
of a generally poor status for nutrients related to one-carbon metabolism in the Tamil Nadu 
area. Marginal plasma vitamin B12 levels defined as <221 pmol/L (Green, Allen et al. 2017) were 
found in 45.8 and 24.0 percent of cases and controls respectively. The high prevalence of 
marginal plasma vitamin B12 status observed among Tamil Nadu control women is uncommon 
in North American and European populations but is common and even higher in many South 
Asian, African, and Latin American populations.   Marginal vitamin B12  status defined by plasma 
MMA >27 umol/L(Green, Allen et al. 2017)  was found in 76.6 percent of cases and 80.0 
percent of controls. Marginal plasma folate defined as <10 nmol/L (Bailey, Stover et al. 2015) 
was found in 29.2 and 33.3 percent of cases and controls respectively.  Elevated tHcy defined 
as >8.0 umol/L (Green, Allen et al. 2017) was found in 79.2 percent of cases and 86.0 percent 
of controls.   
The validation studies which compared blinded assays of plasma vitamin B12 and folate 
from two independent laboratories using different analytical methods added confidence to the 
accuracy of the overall results.  The two methods of assaying plasma vitamin B12 each showed 
close agreement to each other and both had similar correlations with MMA and tHcy, and no 
significant correlations with folate. The two methods of assaying folate status showed close 
agreement to each other and similar correlations with tHcy and no significant correlations with 
vitamin B12 or MMA.  Validation studies are important to include in future publications as it has 
been shown that assay variations between laboratories affect the results of population-based 
studies and to ensure greater comparability between studies assay harmonization is 
needed.(Pfeiffer, Zhang et al. 2011)   
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 In developing countries such as India breastfeeding at the time of maternal blood sample 
collection may result in nutrient biomarker levels different than non-breastfeeding 
mothers.(Jathar, Kamath et al. 1970, Obeid, Sole-Navais et al. 2017)  However in the better 
nourished populations of Europe and North America there may be less of an effect of 
breastfeeding on blood nutrient levels. Longitudinal studies among women in Denmark found no 
significant changes in maternal serum cobalamins between three weeks and nine months post-
partum and the means for the lactating women were similar to reference levels for non-lactating 
women. (Ramlau-Hansen, Moller et al. 2006, Morkbak, Ramlau-Hansen et al. 2007)  We found 
that plasma B12 was lower and MMA was higher in breastfeeding (BF) vs. non-breastfeeding 
(NBF) mothers in both case and control-mothers when these groups were examined separately. 
In analyses that were restricted to non-breastfeeding mothers only compared to the total sample 
the OFC association with low B12 was similar, association with high MMA was higher, and the 
association with the joint level of low B12 and high MMA among NBF only was also higher. 
These additional subgroup analyses of NBF mothers add confidence to the overall findings, but 
the precision of the ORs estimated was limited by the smaller sample size.  A further limitation 
of our study was a lack of information on the duration of breastfeeding immediately preceding 
blood collection.  Future studies should obtain more complete data on breastfeeding, especially 
in the setting of developing countries, and include breastfeeding as a covariate in analyses 
when there are differences in breastfeeding prevalence between the groups compared. 
The role of maternal nutrition in OFCs in India is of global public health importance 
because of India’s large and diverse populations, widespread marginal nutritional status of 
women of reproductive age (Kumar, Taneja et al. 2017), and dietary patterns that are quite 
different from North American and European populations.  Diets with low intakes of animal foods 
are common in Tamil Nadu and other states in India resulting in a high prevalence of vitamin B12 
deficiency which has been linked to many adverse reproductive health outcomes including 
spontaneous abortion, intrauterine growth retardation, fetal adiposity, and insulin resistance, 
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and gestational diabetes.(Muthayya, Kurpad et al. 2006, Yajnik, Deshpande et al. 2008, 
Krishnaveni, Hill et al. 2009, Katre, Bhat et al. 2010).  In a review of worldwide studies of the 
prevalence of marginal vitamin B12 levels, the South Asian populations were among the highest, 
ranging between 27 and 72 percent (Green, Allen et al. 2017).  Several studies among women 
of reproductive age in India have found a relatively high prevalence of vitamin B12 deficiency 
combined with a low prevalence of folate deficiency, unlike trends in Western populations with 
much higher intakes of animal foods and lower intakes of vegetable foods. (Pathak, Kapil et al. 
2007, Yajnik, Deshpande et al. 2008, Bansal, Toteja et al. 2016, Sivaprasad, Shalini et al. 2016)    
Iron-folate supplements are routinely distributed to pregnant women in India for the control of 
anemia and a concern has emerged that elevated folate levels in the presence of low vitamin 
B12 levels may be associated with adverse pregnancy outcomes including increased risk of 
obesity, insulin resistance, and diabetes (Rosenberg 2008, Yajnik, Deshpande et al. 2008, Paul 
and Selhub 2017) however this is still somewhat controversial and requires further study.   
Additional studies of maternal nutritional biomarkers in a variety of settings and using 
standardized laboratory methods would give a clearer view of associations between nutrients 
involved in one-carbon metabolism and risk of OFCs. Further studies are also needed of 
specific molecular forms of folate. Blood folate concentrations in persons with vitamin B12 
deficiency cannot be assumed to mean that their functional folate status is adequate. In the 
presence of vitamin B12 deficiency folate may be “trapped” in the unusable methyl-form (Herbert 
and Zalusky 1962, Green, Allen et al. 2017) and description of the distribution of various folate 
molecular forms may provide additional insight into impaired folate metabolism.     
In conclusion the Tamil Nadu OFC study found that low maternal vitamin B12 status is 
widespread and approximately 6.5 times more likely among mothers of CL+P children 
compared to control mothers.  The potential role of improved vitamin B12 status for the 
prevention of OFCs is of considerable interest among the large populations of India and the 
broader South Asia region with low intakes of animal foods containing vitamin B12, an area that 
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includes nearly one fourth of the world’s population. (The_World_Bank 2017)  Further studies of 
dietary practices and assessment with multiple biomarkers of nutrients involved in one-carbon 
metabolism in populations with diverse nutritional backgrounds are needed to establish whether 
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Table 1. Characteristics of case and control mothers and children in the Tamil Nadu, India, 






N = 47 
Controls 
 








Age of index child at blood draw (years) 
 




22 (20, 24) 
 
155 (150, 157) 
 
54.0 (48.0, 59.8) 
 
















232.0 (173.5, 323.2) 
 




24.0 (21, 26) 
 
151.0 (148, 158) 
 
50 (44.8, 61.3) 
 
















Sex of index child (female percent) 
 
Age of mother at blood draw (years) 
 
Height of mother (cm) 
 
Weight of mother (kg) 
 














Vitamin B12 pmol/L4   
 
 
286.3 (222.5, 336.4) 
 
Methylmalonic acid umol/L5 
 
 
0.36  (0.28, 0.52) 
 





10.7 (8.3, 12.6) 
 
9.6 (8.7, 12.3 
 
Folate (nmol/L)6  
 
 
10.7 (8.1, 13.5) 
 





Table 1 (continued) 
1Index cases are children with cleft lip with or without cleft palate and no other birth defects 
2IQR: inter-quartile range 
3Includes direct breastfeeding and expressing breast milk for infant feeding at time of blood 
collection 
4Determination by electrochemiluminescence method; (Elecsys 2010, Roche Diagnostics, 
Mannheim, Germany) (Duggan, Srinivasan et al. 2014) 
5Determination by chromatography-mass spectrometry method; (Varian 3800, Palo Alto, CA, 
USA) (Duggan, Srinivasan et al. 2014) 
6Determination by microbiological method (Molloy and Scott 1997); sample includes 29 cases 





Table 2. Spearman rank-order correlations (r) between maternal nutrient biomarkers related to 
folate-dependent one-carbon metabolism; Tamil Nadu, India, Orofacial Cleft Study (47 case and 
50 control mothers combined)  
 
 





Maternal nutrient biomarker  
 




























     
 
 



































   
































































Table 2 (continued) 
1B12-ECL: electrochemiluminescence method; (Elecsys 2010, Roche Diagnostics, Mannheim, 
Germany) (Duggan, Srinivasan et al. 2014) 
2B12-MB: microbiological method for plasma vitamin B12 (58 validation samples) (Kelleher and 
Broin 1991) 
3Gas chromatography-mass spectrometry method; (Varian 3800, Palo Alto, CA, USA) (Duggan, 
Srinivasan et al. 2014) 
4Folate-MB: microbiological method for plasma folate determination (Molloy and Scott 1997) 
5Folate-LC-MS/MS: liquid chromatography-tandem mass spectrometry method for plasma folate 
determination (33 validation assays) 
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Table 3.  Relative odds (odds ratios and 95 percent confidence intervals) estimates of associations between nutrient biomarker levels 


















Unadjusted Odds ratio 
(95% Confidence interval) 
Adjusted1 Odds ratio 
 
























2.36 (1.02, 5.44) 
 







Below median  
 









Above median  
 






1.94 (0.85 ,4.40) 
 

























1.61 (0.72, 3.62) 
 





Above median  
 









Below median  
 






2.00 (0.75, 5.32) 
 




Table 3 (continued) 
1Covariates in logistic regression model:  age of mother, rural vs urban residence, and breastmilk feeding or expression at the time of 
blood collection (yes vs.no), 
2B12-ECL: electrochemiluminescence method; (Elecsys 2010, Roche Diagnostics, Mannheim, Germany) (Duggan, Srinivasan et al. 
2014) 
3Gas chromatography-mass spectrometry method; (Varian 3800, Palo Alto, CA, USA) (Duggan, Srinivasan et al. 2014) 
4F-MB: microbiological method for plasma folate determination (Molloy and Scott 1997); includes fewer nine participants due to 





Table 4. Relative odds (odds ratios and 95 percent confidence intervals) estimates of associations between nutrient biomarker levels 
and mothers of orofacial cleft children (isolated cleft lip with or without cleft palate) by combinations of high and low levels of maternal 























Odds ratio  
 





































0.96 (0.26, 3.56) 
 
0.90 (0.17, 4.80) 
Higher risk 
 










1.27 (0.36, 4.48) 
 
0.74 (0.15, 3.48) 
Higher risk 
 










3.13 (1.05, 9.27) 
 
6.54 (1.33, 32.09) 
 
1Covariates in logistic regression model:  age of mother, rural vs urban residence, breastmilk feeding or expression at the time of blood 
collection (yes vs no). 
 
2B12-ECL: electrochemiluminescence method; (Elecsys 2010, Roche Diagnostics, Mannheim, Germany) (Duggan, Srinivasan et al. 
2014) 
 
3Gas chromatography-mass spectrometry method; (Varian 3800, Palo Alto, CA, USA) (Duggan, Srinivasan et al. 2014) 
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